[1] Lordkipanidzé M, Pharand C, Schampaert E, et al. A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease[J] . Eur Heart J, 2007, 28(14):1702-1708.
[2] Pearson TA,Mensah GA,Alexander RW,et al.Markers of inflammation and cardiovascular disease:application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association[J] . Circulation,2003,107(3):499-511.
[3] Weber AA,Przytulski B,Schanz A,et al. Towards a definition of aspirin resistance:a typological approach[J] .Platelets,2002, 13(1):37-40.
[4] Collet JP, Montalescot G. Platelet function testing and implications for clinical practice[J] . J Cardiovasc Pharmacol Ther, 2009, 14(3):157-169.
[5] Blais N, Pharand C, Lordkipanidzé M, et al. Response to aspirin in healthy individuals. Cross-comparison of light transmission aggregometry, VerifyNow system, platelet count drop, thromboelastography (TEG) and urinary 11-dehydrothromboxane B(2)[J] . Thromb Haemost, 2009, 102(2):404-411. |